4//SEC Filing
ALEXION PHARMACEUTICALS INC 4
Accession 0000899866-17-000010
CIK 0000899866operating
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:36 PM ET
Size
8.6 KB
Accession
0000899866-17-000010
Insider Transaction Report
Form 4
BELL LEONARD
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock, par value $.0001 per share
2017-01-10$22.90/sh+100$2,290→ 403,719 total - Sale
Common Stock, par value $.0001 per share
2017-01-10$144.99/sh−100$14,499→ 403,619 total - Sale
Option to Purchase Common Stock
2017-01-10$22.90/sh−100$2,290→ 76,838 totalExercise: $22.90From: 2010-04-28Exp: 2020-01-28→ Common Stock, par value $.0001 per share (100 underlying)
Footnotes (2)
- [F1]The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $144.99 - $145.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899866
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:36 PM ET
- Size
- 8.6 KB